This morning, the Department of Health and Human Services (HHS) announced a Notice of Proposed Rule Making (NPRM) to review two potential ways to allow “safe” importation of certain drugs originally intended for foreign markets. No secretary of Health and Human Services or commissioner of the Food and Drug Administration (FDA) under a Republican or […]
Kamala Harris’s Medicare for All Plan: Just Another Gateway to Socialized Healthcare
Bottom line: Sen. Harris’s plan is just another entry way to force government-run healthcare on everyone.
Is the Prescription Drug Pricing Reduction Act Another Obamacare?
For weeks, there was little information on what would be in the legislation since it was being discussed and written behind closed doors.
Colorado and California Take Action to Lower Obamacare Premiums
A July 23, 2019 Inside Health Policy healthcare column discusses predictions made by Colorado and California state officials on the cost of their insurance premiums in 2020 due to actions they took to make the Patient Protection and Affordable Care Act (ACA), or Obamacare, more affordable. Colorado applied for a 1332 state innovation waiver that […]
Socialist Drug Price Controls Should be Rejected
It has been often said that in Washington, D.C. bad news comes out on a Friday afternoon and today, July 19, 2019, is no exception
V.P. Biden’s Plan is Really a Side Door to Medicare for All
Today, former Vice President and 2020 Democratic presidential candidate Joe Biden offered his healthcare plan, the “Affordable Care Act 2.0.” It would keep and build on Obamacare and provide a public option or mechanism for people to buy into a government-run plan. Biden says he would provide “free premiums” to low-income people that live in […]
CAGW Weighs In on Important Announcements on Drug Pricing
Two important news items regarding pharmaceutical prices have been announced within the past week: a judge’s decision on a Trump administration rule that would have forced drug companies to provide the wholesale acquisition cost (WAC) of a drug in their television ads and a forthcoming executive order concerning drug prices.
Senate Finance Committee Drug Pricing Changes – Market Driven or More Destructive Price Controls?
Senate should be reminded when considering drug plans for Medicare and Medicaid that competition always leads to lower drug costs.
Hang Onto Your Wallets … And Your Freedom
Listening to the Democratic presidential debates these past two days has been alarming. Pandering to specific groups, the candidates are prepared to have the federal government cover the costs for a myriad of programs. The New York Times wrote, “The Democrats’ two nights of debates showed that liberalism is on the march in the party. […]
No More Vaping in San Francisco?
The Los Angeles Times’s June 24 editorial, “San Francisco’s E-cigarette Ban Isn’t Just Bad Policy, it’s Bad for Public Health” is right on target. Today, San Francisco’s Board of Supervisors is scheduled to vote on banning the sales of electronic tobacco products, or e-cigarettes, within the city until the Food and Drug Administration adopts regulations […]










